QIAN TU: Open Payments
NPI 1528693223 · AUBURN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 21 payments from 5 companies in 2025. Trend: 2023 $47 · 2024 $187 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Insmed, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: DUPIXENT, FASENRA, TRELEGY ELLIPTA, Arikayce, XOLAIR, BREZTRI.
Industry payments across WA — which companies pay providers there.
